🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
The purpose of this study is to identify patients who may be eligible to pa...
Status
Completed
Location
Miami Cancer Institute
Start Date
2021-12-14
Trial ID
NCT05158621
The investigators hypothesize that a personalized neoantigen vaccine combin...
Status
Active Not Recruiting
Location
Washington University School of Medicine
Start Date
2022-03-30
Trial ID
NCT04397003
Treatments Being Tested
This is a single-arm, open-label, multi-site Phase I/IIa study of a persona...
Status
Active Not Recruiting
Location
Johns Hopkins Hospital
Start Date
2020-03-01
Trial ID
NCT04251117
Treatments Being Tested
This is a single institution, open-label, multi-arm, phase I study assessin...
Status
Active Not Recruiting
Location
Washington University School of Medicine
Start Date
2023-10-27
Trial ID
NCT05743595
Treatments Being Tested
This is a phase 1 open-label study to evaluate the safety and immunogenicit...
Status
Terminated
Location
Johns Hopkins School of Medicine
Start Date
2018-01-05
Trial ID
NCT03122106
Treatments Being Tested
This is a phase 1, open-label, multicentric study evaluating the safety, fe...
Status
Not Yet Recruiting
Location
CHRU Jean Minjoz
Start Date
2026-11-01
Trial ID
NCT07587827
The purpose of this research study is to learn about the safety and feasibi...
Status
Recruiting
Location
Washington University School of Medicine
Start Date
2024-10-02
Trial ID
NCT03988283
Treatments Being Tested
NECVAX-NEO1 in addition to anti-PD-1 or anti-PD-L1 monoclonal antibody chec...
Status
Active Not Recruiting
Location
Kaunas University Hospital
Start Date
2022-05-05
Trial ID
NCT05354323
Treatments Being Tested
Microlyvaq™ is a first-line, non-randomized, two-arm clinical trial in adva...
Status
Enrolling By Invitation
Location
Biogenea Pharmaceuticals Ltd
Start Date
2026-02-02
Trial ID
NCT07285434
Treatments Being Tested
This is a randomized, open-label, multi-site Phase II study of a personaliz...
Status
Recruiting
Location
Emory University
Start Date
2026-09
Trial ID
NCT07722741